Abbott: Atherosclerosis trials

The registry lists 10 Atherosclerosis studies with Abbott as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 2 1Phase 3 1Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• ILUMIEN IV: OPTIMAL Percutaneous Coronary Intervention (PCI)CompletedNCT03507777Not applicableResults posted
• ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) SystemCompletedNCT01468974Not applicableResults posted
• SPIRIT Small Vessel RegistryTerminatedNCT00783796Not applicableResults posted
• Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)TerminatedNCT00106938Not applicableResults posted
• The ABSORB BTK (Below The Knee) Clinical InvestigationTerminatedNCT01341340Not applicable
• XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in DeliveryCompletedNCT00731237
• A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent SystemCompletedNCT00475566Not applicable
• Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)CompletedNCT00287508Phase 4
• ACCULINK for Revascularization of Carotids in High Risk Patients "The ARCHeR Trial"CompletedNCT00180518Phase 2/3
• Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELLCompletedNCT00079638Phase 4